IPSC Laboratory for CNS Disease Modeling
1 – 20 of 51
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer's disease pathogenesis
(
- Contribution to journal › Article
-
Mark
Human iPSC-derived microglia carrying the LRRK2-G2019S mutation show a Parkinson’s disease related transcriptional profile and function
(
- Contribution to journal › Article
-
Mark
Pathogen-driven degradation of endogenous and therapeutic antibodies during streptococcal infections
(
- Contribution to journal › Article
-
Mark
Inhibition of the serine protease HtrA1 by SerpinE2 suggests an extracellular proteolytic pathway in the control of neural crest migration
(
- Contribution to journal › Article
- 2022
-
Mark
Parkinson's disease and multiple system atrophy patient iPSC-derived oligodendrocytes exhibit alpha-synuclein-induced changes in maturation and immune reactive properties
(
- Contribution to journal › Article
-
Mark
Canonical Bone Morphogenetic Protein Signaling Regulates Expression of Aquaporin-4 and Its Anchoring Complex in Mouse Astrocytes
(
- Contribution to journal › Article
- 2021
-
Mark
Generation of the human pluripotent stem-cell-derived astrocyte model with forebrain identity
(
- Contribution to journal › Article
-
Mark
TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration
(
- Contribution to journal › Article
-
Mark
The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregation
(
- Contribution to journal › Article
-
Mark
Urokinase plasminogen activator mediates changes in human astrocytes modeling fragile X syndrome
(
- Contribution to journal › Article
- 2020
-
Mark
NF-E2-related factor 2 activation boosts antioxidant defenses and ameliorates inflammatory and amyloid properties in human Presenilin-1 mutated Alzheimer's disease astrocytes
(
- Contribution to journal › Article
-
Mark
Unique signatures of stress-induced senescent human astrocytes
(
- Contribution to journal › Article
-
Mark
Stem cell-based models to study cellular alterations in Parkinson’s Disease
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Human iPSC-Derived Hippocampal Spheroids : An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies
(
- Contribution to journal › Article
-
Mark
Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene
(
- Contribution to journal › Article
-
Mark
Oligodendroglial (dys)function in alpha-synucleinopathies
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2019
-
Mark
Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene
(
- Contribution to journal › Article
-
Mark
PARK2 mutation causes metabolic disturbances and impaired survival of human iPSC-derived neurons
(
- Contribution to journal › Article
-
Mark
FGF family members differentially regulate maturation and proliferation of stem cell-derived astrocytes
(
- Contribution to journal › Article